$379.96
1.38%
NYSE, Sep 24, 04:03 pm EDT. Closed.
ISIN
US4448591028
Symbol
HUM

Humana Target price 2026 - Analyst rating & recommendation

Humana Classifications & Recommendation

Buy
48%
Hold
48%
Sell
3%

Humana Price Target

Target Price $423.30
Price $380.32
Potential
Number of Estimates 28
28 Analysts have issued a price target Humana 2027 . The average Humana target price is $423.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 33 analysts: 16 Analysts recommend Humana to buy, 16 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Humana stock has an average upside potential 2027 of . Most analysts recommend the Humana stock at Buy or hold.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 129.66 164.23
10.11% 26.66%
EBITDA Margin 3.17% 1.71%
3.99% 45.97%
Net Margin 0.92% 0.68%
10.61% 25.78%

27 Analysts have issued a sales forecast Humana 2026 . The average Humana sales estimate is

$164b
unlock
. This is
12.73% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$172b 18.00%
unlock
, the lowest is
$158b 8.69%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $130b 10.11%
2026
$164b 26.66%
unlock
2027
$170b 3.43%
unlock
2028
$181b 6.57%
unlock
2029
$195b 7.67%
unlock
2030
$210b 7.56%
unlock
2031
$236b 12.34%
unlock
2032
$253b 7.58%
unlock
2033
$272b 7.50%
unlock

22 Analysts have issued an Humana EBITDA forecast 2026. The average Humana EBITDA estimate is

$2.8b
unlock
. This is
32.60% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$3.2b 21.99%
unlock
, the lowest is
$2.3b 45.10%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $4.1b 5.72%
2026
$2.8b 31.73%
unlock
2027
$4.3b 52.53%
unlock
2028
$6.0b 41.32%
unlock
2029
$6.5b 8.28%
unlock
2030
$7.3b 11.87%
unlock
2031
$8.0b 9.03%
unlock
2032
$8.3b 4.22%
unlock
2033
$8.7b 4.25%
unlock

EBITDA Margin

2025 3.17% 3.99%
2026
1.71% 45.97%
unlock
2027
2.52% 47.37%
unlock
2028
3.34% 32.54%
unlock
2029
3.36% 0.60%
unlock
2030
3.49% 3.87%
unlock
2031
3.39% 2.87%
unlock
2032
3.28% 3.24%
unlock
2033
3.18% 3.05%
unlock

30 Humana Analysts have issued a net profit forecast 2026. The average Humana net profit estimate is

$1.1b
unlock
. This is
13.23% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.3b 4.00%
unlock
, the lowest is
$995m 22.23%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $1.2b 1.57%
2026
$1.1b 6.58%
unlock
2027
$2.0b 80.16%
unlock
2028
$3.3b 62.74%
unlock
2029
$3.7b 12.77%
unlock
2030
$4.1b 12.80%
unlock
2031
$4.0b 3.55%
unlock
2032
$4.2b 5.80%
unlock
2033
$4.4b 4.22%
unlock

Net Margin

2025 0.92% 10.61%
2026
0.68% 25.78%
unlock
2027
1.18% 73.53%
unlock
2028
1.80% 52.54%
unlock
2029
1.88% 4.44%
unlock
2030
1.97% 4.79%
unlock
2031
1.70% 13.71%
unlock
2032
1.67% 1.76%
unlock
2033
1.62% 2.99%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 9.83 9.24
1.60% 6.00%
P/E 41.15
EV/Sales 0.32

30 Analysts have issued a Humana forecast for earnings per share. The average Humana EPS is

$9.24
unlock
. This is
12.50% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$11.08 4.92%
unlock
, the lowest is
$8.28 21.59%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $9.83 1.60%
2026
$9.24 6.00%
unlock
2027
$16.65 80.19%
unlock
2028
$27.10 62.76%
unlock
2029
$30.56 12.77%
unlock
2030
$34.47 12.79%
unlock
2031
$33.25 3.54%
unlock
2032
$35.18 5.80%
unlock
2033
$36.66 4.21%
unlock

P/E ratio

Current 36.02 86.02%
2026
41.15 14.26%
unlock
2027
22.84 44.50%
unlock
2028
14.03 38.57%
unlock
2029
12.45 11.26%
unlock
2030
11.03 11.41%
unlock
2031
11.44 3.72%
unlock
2032
10.81 5.51%
unlock
2033
10.37 4.07%
unlock

Based on analysts' sales estimates for 2026, the Humana stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.36 12.50%
2026
0.32 10.31%
unlock
2027
0.31 3.34%
unlock
2028
0.29 6.15%
unlock
2029
0.27 7.14%
unlock
2030
0.25 7.02%
unlock
2031
0.23 10.99%
unlock
2032
0.21 7.02%
unlock
2033
0.19 6.98%
unlock

P/S ratio

Current 0.31 27.03%
2026
0.28 11.29%
unlock
2027
0.27 3.34%
unlock
2028
0.25 6.14%
unlock
2029
0.23 7.13%
unlock
2030
0.22 7.04%
unlock
2031
0.19 10.97%
unlock
2032
0.18 7.01%
unlock
2033
0.17 6.99%
unlock

Current Humana Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
➜
Locked
Locked Aug 10 2026
Morgan Stanley
Locked
➜
Locked
Locked Aug 05 2026
Barclays
Locked
➜
Locked
Locked Jul 31 2026
TD Cowen
Locked
➜
Locked
Locked Jul 31 2026
Guggenheim
Locked
➜
Locked
Locked Jul 30 2026
Evercore ISI Group
Locked
➜
Locked
Locked Jul 30 2026
Raymond James
Locked
➜
Locked
Locked Jul 30 2026
Analyst Rating Date
Locked
JP Morgan:
Locked
➜
Locked
Aug 10 2026
Locked
Morgan Stanley:
Locked
➜
Locked
Aug 05 2026
Locked
Barclays:
Locked
➜
Locked
Jul 31 2026
Locked
TD Cowen:
Locked
➜
Locked
Jul 31 2026
Locked
Guggenheim:
Locked
➜
Locked
Jul 30 2026
Locked
Evercore ISI Group:
Locked
➜
Locked
Jul 30 2026
Locked
Raymond James:
Locked
➜
Locked
Jul 30 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today